Frontiers in Immunology, 2026 Multidimensional neuropsychological heterogeneity in obstructive sleep apnea: deep clinical phenotyping in a single-center cohort, population proteomic context, and depressive-burden risk stratification Wang X., Jiang Y., Yu L. et al. Olink Explore 3072/384Respiratory DiseasesNeurologyPatient StratificationPlasma | | | | |
Frontiers in Psychiatry, 2026 A discovery plasma proteome signature in military personnel with chronic PTSD symptoms Lim A., Robey C., Kenney K. et al. Olink Explore HTNeurologyPathophysiologyPatient Stratification | | | | |
Brain, Behavior, and Immunity, 2026 DREADDs-Gi mediated inhibition of myeloid cells leads to anti-inflammatory signalling, shrinkage of microglia and acute heart failure in Cx3cr1Cre mice Holde F., Pedersen T., Frandsen S. et al. Olink Target 96 MouseCVDPathophysiologyMouse Plasma | | | | |
Clinical Proteomics, 2026 Pre-surgical immune-proteomic profiles in serum identify inflamed and suppressed immune states associated with biochemical recurrence and PSA persistence in prostate cancer Desiati I., Bozorgpana S., Ramberg H. et al. Olink Target 96OncologyPatient StratificationSerum | | | | |
Journal of Neurology, 2026 Decreased cerebrospinal fluid TNFRSF8 (sCD30) confirmed as a biomarker of Huntington’s disease progression Grétarsdóttir H., Cunningham J., Rasmusson A. et al. Olink Explore 3072/384NeurologyPathophysiologyPatient StratificationCSF | | | | |
International Journal of Radiation Oncology*Biology*Physics, 2026 Safety and Biomarker Analysis of NRG-LU004: Phase I Trial of Accelerated or Conventionally Fractionated Radiotherapy Combined With Durvalumab in PD-L1 High Locally Advanced Non-Small Cell Lung Cancer Lin S., Pugh S., Valle D. et al. Olink Target 96OncologyImmunotherapyPathophysiologyPlasma | | | | |
Experimental Gerontology, 2026 Proteomic signatures of systemic inflammation in aging, multimorbidity, and mortality Jiang Z., Ling D., Chen Z. et al. Olink Explore 3072/384AgingPathophysiologyPlasma | | | | |
Cell Death & Disease, 2026 A pro-inflammatory metastasis-associated macrophage subset induces tumor-promoting mesothelial cell conversion in ovarian cancer via IL-1α secretion Heidemann S., Finkernagel F., Steitz A. et al. Olink Explore 3072/384OncologyPathophysiologyCell Culture Supernatant | | | | |
PLOS Medicine, 2026 Protein mediators of chronic kidney disease in Type 2 diabetes: A mendelian randomization study Liang K., Zheng T., Tan D. et al. Olink Explore 3072/384Metabolic DiseasesNephrologyPathophysiologyPlasma | | | | |
International Journal of Molecular Sciences, 2026 Integrative Proteogenomics and Single-Cell Transcriptomics Prioritize Candidate Causal Proteins and Therapeutic Targets in Age-Related Macular Degeneration Wen L., Li F., Liu Y. et al. Olink Explore 3072/384OphthalmologyPathophysiologyPlasma | | | | |
Inflammation, 2026 Targeting E-Selectin and ICAM1 Suppresses Endometriosis Progression by Disrupting the Inflammation–Fibrosis Axis and Reducing Local M2 Macrophage Infiltration Wu Y., Ye X., Zheng A. et al. Olink Target 96Immunological & Inflammatory DiseasesGynecologyPathophysiologyMouse Tissue Lysate | | | | |
Nature Metabolism, 2026 Paediatric proteomic signatures of cardiometabolic disease-associated traits predict adult disease outcomes Landman J., Highland H., Perry A. et al. Olink Explore 3072/384Olink Explore HTMetabolic DiseasesCVDNephrologyPathophysiologyPatient StratificationPlasma | | | | |
Clinical and Translational Medicine, 2026 Bevacizumab plus nab‐paclitaxel and platinum as second‐line therapy for driver‐gene‐negative non‐squamous non‐small cell lung cancer after immunochemotherapy: A prospective single‐arm single‐centre study Lin Y., Yu Y., Hu Z. et al. Olink Target 96OncologyImmunotherapyPathophysiologyPlasma | | | | |
European Journal of Medical Research, 2026 Strong molecular regulation of PARK7 with limited causal evidence for lung squamous cell carcinoma susceptibility: an integrative reanalysis Li X., Zhang F., Li Y. et al. Olink Explore 3072/384OncologyPathophysiologyPlasma | | | | |
Journal of Anatomy, 2026 Immune proteomic associations with indices of cortical development in 5‐year‐old children Barron A., Rosberg A., Tuulari J. et al. Olink Explore 3072/384NeurologyPediatricsPathophysiologySerum | | | | |
Heart & Lung, 2026 Glucagon-like peptide-1 receptor activation, inflammation and heart failure: Insights from genetic analysis Tian Y., Sheng C., Zhu J. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
GeroScience, 2026 Parental longevity and polygenic longevity scores in relation to ageing-related factors in a population of 70-year-olds followed over six years: The Gothenburg H70 Birth Cohort Study Seidu N., Rydén L., Skoog J. et al. Olink Target 48AgingPathophysiologyPlasma | | | | |
Thorax, 2026 Markers of microvascular instability predict severity and survival in idiopathic pulmonary fibrosis Csordas D., Ma S., Huang Y. et al. Olink Explore 3072/384Respiratory DiseasesPathophysiologyPatient StratificationPlasma | | | | |
ERJ Open Research, 2026 Circulating proteins in common variable immunodeficiency with granulomatous lymphocytic interstitial lung disease – A Nordic cross-sectional multi-centre study Fraz M., Michelsen A., Hol H. et al. Olink Target 96Respiratory DiseasesImmunological & Inflammatory DiseasesPathophysiologyPatient StratificationPlasma | | | | |
Nature Communications, 2026 Evaluating the consequences of childhood adiposity on the human plasma proteome at four timepoints across the lifecourse Dickson P., Power G., Niu L. et al. Olink Target 96Olink Explore 3072/384Metabolic DiseasesPathophysiologyPlasma | | | | |